3-hydroxybenzylhydrazine has been researched along with MPTP Neurotoxicity Syndrome in 2 studies
3-hydroxybenzylhydrazine: decarboxylase inhibitor; RN given refers to parent cpd; structure
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kozina, EA | 1 |
| Khakimova, GR | 1 |
| Khaindrava, VG | 1 |
| Kucheryanu, VG | 1 |
| Vorobyeva, NE | 1 |
| Krasnov, AN | 1 |
| Georgieva, SG | 1 |
| Kerkerian-Le Goff, L | 1 |
| Ugrumov, MV | 1 |
| Richard, MG | 1 |
| Bennett, JP | 1 |
2 other studies available for 3-hydroxybenzylhydrazine and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Corpus Striatum; Disease Models, Animal; Dopa | 2014 |
Regulation by D2 dopamine receptors of in vivo dopamine synthesis in striata of rats and mice with experimental parkinsonism.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Corpus Striatum; Dihydroxyphenylalanine; Dopa | 1994 |